Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence
- 1 March 2004
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 20 (4) , 322-329
Abstract
Background: To develop screening strategies for identification of individuals at increased genetic risk for type 1 diabetes in three populations with variable disease incidence rates and distinct ethnic origin.Methods: A stepwise HLA DQB1‐DQA1‐DRB1‐based screening approach was evaluated. Patients with childhood‐onset type 1 diabetes were recruited from Finland (n = 1739), Hungary (n = 149), and Greece (n = 119). Consecutive newborns (2568 from Finland and 1047 from Greece) or healthy schoolchildren (n = 177 from Hungary) served as controls.Results: The DQB1*02/0302 genotype conferred the highest disease risk in all populations. The DQB1*02/y (y ≠ DQB1*0301,*0302,*0602,*0603, *0604) genotypes were more common and conferred a higher disease risk in the Greek population (OR 4.9) compared to the Finns (OR 1.2). DQB1*0302/x (x ≠ DQB1*02, *0301, *0602, *0603, *0604) genotypes were, in contrast, more prevalent among Finnish cases (32.7%) as compared to Hungarians (18.1%) or Greeks (13.5%). The protective DQB1*0602 or *0603 positive genotypes were most common in the Finns, while DQB1*0301 was more common in Hungarians and Greeks. In all groups, DQA1 and DRB1*04 typing considerably increased the sensitivity of the DQB1‐based screening. The different high‐risk genotype combinations present in about 10% of the background population had a diagnostic sensitivity of 60% in Finland and 80% in Hungary and Greece.Conclusions: HLA DR‐DQ‐based screening is a feasible tool for the identification of individuals at increased genetic risk for type 1 diabetes in populations with diverse genetic background. The risk markers should, however, be individually selected for the target population since the screening efficiency of various markers is highly dependent on the ethnic group studied. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- HLA DR‐DQ‐encoded genetic determinants of childhood‐onset type 1 diabetes in Finland: An analysis of 622 nuclear familiesTissue Antigens, 2003
- Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes—indication of an increased environmental pressure?Diabetologia, 2003
- Effect of coincident enterovirus infection and cows' milk exposure on immunisation to insulin in early infancyDiabetologia, 2002
- HLA class II associated risk and protection against multiple sclerosis—a Finnish family studyJournal of Neuroimmunology, 2002
- The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region)Tissue Antigens, 2001
- Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohortDiabetologia, 2001
- Costs of predicting IDDMDiabetologia, 1998
- Susceptibility to type I diabetes: HLA-DQ and DR revisitedImmunology Today, 1996
- Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY)Diabetologia, 1996
- Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE studyThe Lancet, 1992